Related Experiment Video
Updated: Apr 21, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Withania somnifera Root Extract Ameliorates PTU-Induced Hypothyroidism by Regulating Hormone Levels and Gene
Md Saud Hossain1, Md Shah Poran Shuvo1, M Maruf Hasan Talukder1
1Department of Biochemistry and Molecular Biology Mawlana Bhashani Science and Technology University Tangail Bangladesh.
This study shows that Withania somnifera root extract effectively treats hypothyroidism in rats by normalizing thyroid hormone levels and improving thyroid gland health. It offers a potential alternative to traditional hormone replacement therapies.
Area of Science:
- Endocrinology
- Pharmacology
- Herbal Medicine Research
Background:
- Hypothyroidism, a common endocrine disorder, results from insufficient thyroid hormone production (T3 and T4).
- Current treatments like synthetic hormone replacement have limitations and potential adverse effects.
- Investigating natural compounds for hypothyroidism treatment is crucial for developing safer alternatives.
Purpose of the Study:
- To evaluate the therapeutic efficacy of a methanolic extract of Withania somnifera root (MEWS) in a rat model of hypothyroidism.
- To assess MEWS's impact on thyroid hormone levels, gene expression, and thyroid gland histology.
- To identify potential bioactive compounds in MEWS targeting key thyroid regulatory pathways using computational methods.
Main Methods:
- Propylthiouracil (PTU) was used to induce hypothyroidism in Wistar rats.
- Rats were treated with varying doses of MEWS, and controls received no treatment or PTU alone.
- Serum hormone levels (TSH, T3, T4), thyroid histopathology, TPO and TG gene expression, molecular docking, and ADMET profiling were analyzed.
Main Results:
- PTU-induced hypothyroidism significantly altered thyroid weight, TSH, T3, T4 levels, and TPO/TG gene expression.
- MEWS treatment significantly reversed these alterations, restoring hormone levels and reducing thyroid weight and gene expression.
- Histopathology showed improved thyroid follicular architecture and reduced fibrosis; computational analysis identified potential bioactive compounds targeting TSHR and D2.
Conclusions:
- Methanolic extract of Withania somnifera root (MEWS) demonstrates significant efficacy in ameliorating PTU-induced hypothyroidism in rats.
- MEWS normalizes thyroid hormone balance, regulates key gene expression, and improves thyroid morphology.
- Withania somnifera shows promise as an adjunct or alternative therapy for hypothyroidism, supported by its phytochemical profile and computational validation.
Related Concept Videos
Hyperthyroidism I: Introduction
Hypothyroidism II: Pathophysiology
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

